Table 4.
LADA | Classic T1DM | |||
---|---|---|---|---|
OR (95%CI) | p-Value | OR (95%CI) | p-Value | |
Age, years | 0.0219* | <0.0001* | ||
30–39 vs ≥50 | 1.32(1.02–1.71) | 3.51(2.53–4.89) | ||
40–49 vs ≥50 | 1.16(0.93–1.44) | 1.35(0.95–1.90) | ||
BMI | 0.0069* | 0.0007* | ||
Overweight | 0.74(0.59–0.94) | 0.52(0.36–0.79) | ||
Obesity | 0.66(0.45–0.98) | 0.40(0.19–0.88) | ||
Normal weight | 1.0 | 1.0 | ||
Central obesity | 0.84(0.66–1.05) | 0.1239 | 1.10(0.76–1.60) | 0.6025 |
Family history of diabetes | 0.80(0.65–1.00) | 0.0463 | 0.74(0.54–1.03) | 0.0709 |
BP <130/80 mmHg | 1.32(1.09–1.60) | 0.0045 | 1.16(0.88–1.54) | 0.2849 |
LDL-C <2.6 mmol/L | 1.07(0.88–1.29) | 0.4978 | 1.35(1.02–1.78) | 0.0341 |
TG <1.7 mmol/L | 1.48(1.21–1.81) | 0.0002 | 1.26(0.92–1.73) | 0.1462 |
HDL-C >1.0 mmol/L in male or 1.3 mmol/L in female | 1.15(0.95–1.40) | 0.1555 | 0.94(0.70–1.25) | 0.6586 |
HbA1c <7.0% (53 mmol/mol) | 0.82(0.63–1.07) | 0.1375 | 1.09(0.70–1.71) | 0.6919 |
Fasting C-peptide | 0.0010* | <0.0001* | ||
Upper quartile | 0.66(0.52–0.85) | 0.10(0.05–0.18) | ||
Mid-high quartile | 0.68(0.50–0.93) | 0.11(0.04–0.28) | ||
Mid-low quartile | 0.57(0.39–0.85) | 0.09(0.02–0.43) | ||
Bottom quartile | 1.0 | 1.0 | ||
Postprandial C-peptide | <0.0001* | <0.0001* | ||
Upper quartile | 0.42(0.32–0.54) | 0.13(0.08–0.23) | ||
Mid-high quartile | 0.38(0.28–0.52) | 0.03(0.01–0.13) | ||
Mid-low quartile | 0.45(0.31–0.66) | 0.09(0.02–0.35) | ||
Bottom quartile | 1.0 | 1.0 | ||
Lifestyle | ||||
Current drinking | 0.75(0.57–0.98) | 0.0336 | 0.94(0.65–1.35) | 0.7187 |
Use of drugs | ||||
Antihypertensive drugs | 0.91(0.70–1.19) | 0.4916 | 0.68(0.41–1.14) | 0.1432 |
Lipid lowering drugs | 0.63(0.43–0.91) | 0.0131 | 0.90(0.54–1.53) | 0.7026 |
Insulin | 1.79(1.38–2.32) | <0.0001 | 3.60(2.65–4.89) | <0.0001 |
Alpha-glucosidase inhibitor | 1.41(1.13–1.76) | 0.0025 | 1.21(0.85–1.73) | 0.2933 |
Metformin | 0.99(0.81–1.21) | 0.9285 | 0.58(0.41–0.83) | 0.0025 |
Sulphonylurea | 1.12(0.86–1.47) | 0.4035 | 0.57(0.32–1.03) | 0.0613 |
Note: *p for trend.
Abbreviations: LADA, latent autoimmune diabetes of adults; T1DM, type 1 diabetes mellitus; OR, odds ratio; GLP-1, glucagon-like peptide-1.